Manatuck Hill Partners LLC Acquires Shares of 67,000 Alpha Cognition, Inc. (NASDAQ:ACOG)

Manatuck Hill Partners LLC bought a new stake in shares of Alpha Cognition, Inc. (NASDAQ:ACOG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 67,000 shares of the company's stock, valued at approximately $395,000. Manatuck Hill Partners LLC owned approximately 0.42% of Alpha Cognition at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. National Bank of Canada FI acquired a new position in shares of Alpha Cognition during the fourth quarter valued at about $69,000. Tudor Investment Corp ET AL acquired a new position in Alpha Cognition during the 4th quarter valued at approximately $412,000. MYDA Advisors LLC purchased a new position in shares of Alpha Cognition in the fourth quarter worth $589,000. Aristides Capital LLC purchased a new position in shares of Alpha Cognition in the fourth quarter worth $1,178,000. Finally, ADAR1 Capital Management LLC acquired a new stake in shares of Alpha Cognition during the fourth quarter worth $1,204,000.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ACOG shares. Raymond James upgraded Alpha Cognition to a "moderate buy" rating in a research note on Tuesday, March 25th. HC Wainwright restated a "buy" rating and issued a $20.00 price objective on shares of Alpha Cognition in a research note on Monday, March 31st.

Alpha Cognition Stock Performance

Shares of ACOG stock traded up $0.41 during trading hours on Friday, hitting $6.39. The company's stock had a trading volume of 105,259 shares, compared to its average volume of 79,280. The stock has a 50 day simple moving average of $5.12. Alpha Cognition, Inc. has a 12-month low of $3.75 and a 12-month high of $7.00. The stock has a market cap of $102.37 million, a PE ratio of -2.50 and a beta of 2.50.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) last announced its quarterly earnings results on Monday, March 31st. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.48) by ($0.03).

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.